Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet L Espirito

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2006
Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivorsJeannine S McCune, Dona M Games, Janet L Espirito
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 3, 2008
Paclitaxel-induced sickle cell crisisNicole M Wilson, Janet L Espirito, Vicente Valero, et al.
Advances in Therapy|January 20, 2020
Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase InhibitorsEric Nadler, Melissa Pavilack, Janet L Espirito, et al.
Future Oncology (London, England)|June 5, 2020
Real-world disease burden and outcomes of brain metastases in <i>EGFR</i> mutation-positive non-small-cell lung cancerEric Nadler, Janet L Espirito, Melissa Pavilack, et al.
Clinical Lung Cancer|June 30, 2021
Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community OncologistsDavid M Waterhouse, Wan-Yu Tseng, Janet L Espirito, et al.
JCO Clinical Cancer Informatics|August 29, 2025
Evaluating the Minimal Common Oncology Data Elements Suitability in Enhancing Clinical Observational ResearchMay Terry, Janet L Espirito, Lisa Deister, et al.
Future Oncology (London, England)|January 15, 2025
Real-world study of patients with HR+/ HER2- metastatic breast cancer treated with palbociclib and fulvestrantNicholas Robert, Connie Chen, Justin Doan, et al.
Future Oncology (London, England)|August 26, 2022
Treatment patterns and outcomes in metastatic synovial sarcoma: a real-world study in the US oncology networkShibani Pokras, Wan-Yu Tseng, Janet L Espirito, et al.
Clinical Lung Cancer|March 27, 2018
Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice SettingEric Nadler, Janet L Espirito, Melissa Pavilack, et al.
Gynecologic Oncology|April 30, 2017
Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancerMichael A Bookman, Jerzy E Tyczynski, Janet L Espirito, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2006
Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivorsJeannine S McCune, Dona M Games, Janet L Espirito
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 3, 2008
Paclitaxel-induced sickle cell crisisNicole M Wilson, Janet L Espirito, Vicente Valero, et al.
Advances in Therapy|January 20, 2020
Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase InhibitorsEric Nadler, Melissa Pavilack, Janet L Espirito, et al.
Future Oncology (London, England)|June 5, 2020
Real-world disease burden and outcomes of brain metastases in <i>EGFR</i> mutation-positive non-small-cell lung cancerEric Nadler, Janet L Espirito, Melissa Pavilack, et al.
Clinical Lung Cancer|June 30, 2021
Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community OncologistsDavid M Waterhouse, Wan-Yu Tseng, Janet L Espirito, et al.
JCO Clinical Cancer Informatics|August 29, 2025
Evaluating the Minimal Common Oncology Data Elements Suitability in Enhancing Clinical Observational ResearchMay Terry, Janet L Espirito, Lisa Deister, et al.
Future Oncology (London, England)|January 15, 2025
Real-world study of patients with HR+/ HER2- metastatic breast cancer treated with palbociclib and fulvestrantNicholas Robert, Connie Chen, Justin Doan, et al.
Future Oncology (London, England)|August 26, 2022
Treatment patterns and outcomes in metastatic synovial sarcoma: a real-world study in the US oncology networkShibani Pokras, Wan-Yu Tseng, Janet L Espirito, et al.
Clinical Lung Cancer|March 27, 2018
Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice SettingEric Nadler, Janet L Espirito, Melissa Pavilack, et al.
Gynecologic Oncology|April 30, 2017
Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancerMichael A Bookman, Jerzy E Tyczynski, Janet L Espirito, et al.
Pageof 3